Client handout: Canine hyperadrenocorticism

The device received an FDA breakthrough device designation last year

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to explain treatment for osteoarthritis and the need for individualized patient plans.

The first canine patient has been dosed in the study that aims to demonstrate an increase in longevity and quality of life in dogs treated with LOY-002

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.

Known as "The Street Vet," Kwane Stewart, DVM, has a passion for providing care to pets living with homeless individuals

Wrapping up World Antimicrobial Resistance Awareness Week with these 3 articles